Diabetic Ketoacidosis in Patients With COVID-19

Am J Med Sci. 2021 May;361(5):668-669. doi: 10.1016/j.amjms.2020.11.027. Epub 2020 Nov 25.

Authors

Sanjana Rao¹, Kiran Ali¹, Marcella Rivas², Kenneth Nugent³

Affiliations

¹ Deaprtment of Internal Medicine, Texas Tech University Health Sciences Center, 3601 4th Street, Lubbock, TX 79430, United States.
² CoxHealth Adult Medicine & Endocrinology Specialists, Springfield, MO, United States.
³ Deaprtment of Internal Medicine, Texas Tech University Health Sciences Center, 3601 4th Street, Lubbock, TX 79430, United States. Electronic address: Kenneth.nugent@ttuhsc.edu.

No abstract available

Publication types

Letter

MeSH terms

Adult
COVID-19 Drug Treatment*
COVID-19* / blood
COVID-19* / complications
Diabetes Mellitus, Type 1* / blood
Diabetes Mellitus, Type 1* / drug therapy
Diabetic Ketoacidosis* / blood
Diabetic Ketoacidosis* / drug therapy
Diabetic Ketoacidosis* / etiology
Female
Humans
Male
Middle Aged
SARS-CoV-2 / metabolism*